Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaLiver TransplantationTransplantation ChimeraCyclophosphamideGraft SurvivalTissue DonorsBusulfanCombined Modality TherapyBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsTreatment OutcomeHistocompatibilityBone Marrow DiseasesTransplantation, IsogeneicRecurrenceKidney TransplantationHematopoiesisLeukemia, Myeloid, AcuteMice, Inbred C57BLTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationSurvival AnalysisHematologic NeoplasmsImmunosuppressive AgentsLymphoma, Non-HodgkinRemission InductionChemotherapy, AdjuvantGraft RejectionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyStem Cell TransplantationGraft vs Host ReactionAcute DiseaseDisease-Free SurvivalImmunosuppressionLymphocyte DepletionSurvival RateLeukocyte TransfusionEtoposideHeart TransplantationMyelodysplastic SyndromesActuarial AnalysisSevere Combined ImmunodeficiencyColony-Forming Units AssayT-LymphocytesFollow-Up StudiesHematologic DiseasesCytarabineCarmustineChimeraHLA AntigensPrognosisRetrospective StudiesLung TransplantationAntineoplastic AgentsCyclosporineBone DensityGranulocyte Colony-Stimulating FactorLymphocyte TransfusionMelphalanNuclear FamilyMethotrexateLeukocyte CountPancytopeniaOrgan TransplantationLymphomaHodgkin DiseaseGraft vs Tumor EffectCell DifferentiationGraft vs Leukemia EffectMultiple MyelomaCytomegalovirus InfectionsMice, Inbred BALB CDoxorubicinSpleenFatal OutcomeBone ResorptionFlow CytometryBone NeoplasmsSalvage TherapyAntigens, CD34